What Patients Should Know Before Considering PRP, MFAT, or SVF Injections

A patient may come in after seeing an advertisement for "stem cell therapy" that promises to help them avoid surgery, rebuild cartilage, or reset a joint. Another may have already paid out of pocket for an injection at a cash-pay clinic and want to know whether it was worth it.

These conversations come up often in Jacksonville, Mandarin, Southside, Orange Park, St. Johns, Ponte Vedra, and across Northeast Florida, where regenerative medicine and orthobiologic clinics have grown quickly. The marketing usually blends three different products together: platelet-rich plasma (PRP), microfragmented adipose tissue (MFAT), and stromal vascular fraction (SVF).

They are not interchangeable. Understanding the difference matters for safety, cost, and realistic expectations.

What PRP, MFAT, and SVF actually are

Platelet-rich plasma (PRP) is made by drawing a patient's own blood and spinning it in a centrifuge to concentrate platelets, which contain growth factors involved in healing. It is injected into or around a joint, tendon, or disc.

Microfragmented adipose tissue (MFAT) is a patient's own fat tissue, collected by a small liposuction-style procedure and then mechanically broken down into smaller fragments without enzymes. It contains a mix of cells, including some with regenerative properties, still embedded in their native tissue structure.

Stromal vascular fraction (SVF) starts the same way, with a patient's own fat, but the tissue is broken apart further, often with an enzyme, to isolate a concentrated cell fraction that may include mesenchymal stem cells. This extra processing step is where SVF becomes legally and clinically different from MFAT.

Why the marketing term "regenerative medicine" is misleading

A common misconception is that "regenerative medicine," "orthobiologics," and "stem cell therapy" all describe one well-established treatment. They do not. These terms are often used interchangeably in advertising even though the underlying products have very different levels of processing, regulatory status, and supporting evidence.

Some clinics also use "stem cell" language loosely to describe products, like most MFAT and SVF preparations, that contain only a small fraction of true stem cells among many other cell types. That is a marketing distinction worth knowing before comparing prices or promises between clinics.

How these products are regulated differently

The FDA generally allows minimally manipulated tissue from a patient's own body to be used for a closely related, or "homologous," purpose without separate drug approval. Mechanically processed PRP and MFAT are often argued to fall into this category, though the specific device and processing method still matter.

Enzymatically processed SVF is treated differently. According to FDA guidance, using an enzyme to break down fat and isolate SVF is generally considered more than minimal manipulation, which means it typically requires an approved Investigational New Drug (IND) application or a registered clinical trial before it can be legally offered.

The FDA has published a consumer warning about unapproved regenerative products, including SVF, noting that clinics charging patients for these products outside of an authorized clinical trial may be doing so illegally, and that serious complications, including infections and tumor formation, have been reported with unapproved stem-cell-based products.

What the evidence actually shows

Evidence quality varies by product and by condition, and is still evolving.

PRP has the largest body of research. For knee osteoarthritis, several reviews suggest PRP, particularly leukocyte-poor preparations, may provide meaningful pain relief for some patients compared with placebo or other injections. Evidence for PRP in chronic spine pain and tendon conditions is more mixed, with some studies showing modest short-term benefit and others showing no significant difference from control treatment.

MFAT has a smaller but growing body of clinical trial data, largely focused on knee osteoarthritis, with some studies reporting pain and function improvements lasting up to about a year. Long-term outcomes and comparisons with standard care are still being studied.

SVF has the least high-quality clinical trial evidence for pain and orthopedic conditions relative to how it is marketed, in part because much of its use has occurred outside regulated clinical trials rather than within them.

None of these treatments have been shown to regrow cartilage, reverse arthritis, or guarantee that surgery can be avoided. Claims like these should be treated as a red flag rather than a reason for confidence.

What this means for patients

If a clinic tells you a product will treat "any condition, anywhere in the body," offers a substantial cash discount for booking quickly, or cannot clearly explain how their product is processed and regulated, that is worth pausing on. Legitimate use of an investigational product should occur through a registered clinical trial with informed consent about its unapproved status, not as a routine paid service.

It is also reasonable to ask whether a more established, evidence-based option, such as physical therapy, medication review, or an image-guided injection with a longer track record, makes sense to try first, depending on the diagnosis.

Signs of an unsafe or non-transparent provider

Be cautious of a clinic that:

• Cannot describe the exact product, processing method, or applicable FDA regulatory pathway
• Promises guaranteed relief, cartilage regrowth, or that you will "never need surgery"
• Pressures same-day payment for a large cash sum
• Offers the same product for nearly every joint or condition
• Cannot provide published evidence specific to your diagnosis

Seek prompt medical attention for fever, spreading redness, worsening swelling, or increasing pain at an injection site after any procedure, as these can be signs of infection.

Where this fits into a broader pain-management plan

Depending on the diagnosis, an evaluation for chronic joint or spine pain may include activity modification, physical therapy, medication review, and, in selected patients, image-guided injections such as epidural steroid injections or joint injections that have a longer track record of study. Radiofrequency ablation may also be considered for confirmed facet- or SI-joint-related pain. Whether a regenerative orthobiologic approach fits into that plan depends on the diagnosis, prior treatment, goals, and a clear-eyed look at current evidence.

Questions to ask before considering a regenerative injection

Useful questions include:

• Exactly what product is being used, and how is it processed?
• Does this product require FDA approval or an IND, and does this use fall under that pathway?
• What does published evidence show for my specific diagnosis, not just for "joint pain" in general?
• What is the full cost, and is more than one treatment likely to be needed?
• What would count as a reasonable trial, and what is the plan if it does not help?

The bottom line

PRP, MFAT, and SVF are three different products with different processing, different regulatory status, and different levels of supporting evidence. None should be marketed as a guaranteed cure, and SVF in particular carries real regulatory and safety considerations that deserve a direct conversation before moving forward.

A careful evaluation can help sort out what is actually being offered, whether it is legally and scientifically appropriate for your condition, and how it compares with more established treatment options.

This article is for general educational purposes only and is not a substitute for a medical evaluation. It does not endorse any specific product, clinic, or manufacturer. If you have signs of infection after any procedure, including fever, spreading redness, or worsening swelling, seek medical care promptly.

Frequently Asked Questions

Are PRP, MFAT, and SVF the same thing?

No. PRP (platelet-rich plasma) is concentrated from a patient's own blood. MFAT (microfragmented adipose tissue) and SVF (stromal vascular fraction) are both derived from a patient's own fat, but they are processed differently and are regulated differently by the FDA.

Is PRP FDA-approved for pain or joint conditions?

The devices used to prepare PRP are FDA-cleared, but PRP itself is not FDA-approved as a drug for treating pain or arthritis. Its use for these purposes is generally considered off-label, and evidence varies by condition.

Is stromal vascular fraction (SVF) legal and FDA-approved?

Enzymatically processed SVF is generally considered more than minimally manipulated by the FDA, which means it usually requires an approved Investigational New Drug (IND) application or clinical trial. The FDA has warned consumers that unapproved SVF and stem cell products marketed outside of a clinical trial may be offered illegally and have been linked to serious complications.

Does insurance cover PRP, MFAT, or SVF injections?

Usually not. Most insurance plans, including Medicare, do not cover these injections for orthopedic or spine-related pain because they are considered investigational or not medically necessary by current coverage policy. Most patients pay out of pocket.

What questions should I ask before considering a regenerative injection?

Ask exactly what product will be used and how it is processed, whether it requires FDA approval or an IND, what the published evidence shows for your specific condition, what the total cost is, and what happens if it does not help.

Related patient education

• Why MRI results may not fully explain pain
• When epidural steroid injections help, and when they do not
• When radiofrequency ablation may fit facet-related back or neck pain
• Preparing for your first pain-management visit

Related services

• Arthritis and joint pain care
• Back pain diagnosis and treatment options
• Epidural steroid injection service overview
• Failed back surgery syndrome care